Literature DB >> 25682728

4-Aminoquinoline Derivatives as Potential Antileishmanial Agents.

Luciana M R Antinarelli1, Rafael M P Dias2, Isabela O Souza2, Wallace P Lima3, Jacy Gameiro1, Adilson D da Silva2, Elaine S Coimbra1.   

Abstract

The leishmanicidal activity of a series of 4-aminoquinoline (AMQ) derivatives was assayed against Leishmania amazonensis. This activity against the intracellular parasite was found stronger than for L. amazonensis promastigotes. Neither compound was cytotoxic against macrophages. The compound AMQ-j, which exhibited a strong activity against promastigotes and amastigotes of L. amazonensis (IC50 values of 5.9 and 2.4 μg/mL, respectively) and similar leishmanicidal activity to reference drugs, was chosen for studies regarding its possible mechanism of action toward parasite death. The results showed that the compound AMQ-j induced depolarization of the mitochondrial membrane potential in promastigotes and in L. amazonensis-infected macrophages, but not in uninfected macrophages. Furthermore, the depolarization of the mitochondrial membrane potential was dose dependent in infected macrophages. We have established that promastigotes and L. amazonensis-infected macrophages treated with AMQ-j were submitted to oxidative stress. This is in line with the increase in the level of reactive oxygen species (ROS). Leishmania amazonensis-infected macrophages treated with AMQ-j did not show a significant increase in the production of nitric oxide. Our results indicate the effective and selective action of AMQ-j against L. amazonensis, and its mechanism of action appears to be mediated by mitochondrial dysfunction associated with ROS production.
© 2015 John Wiley & Sons A/S.

Entities:  

Keywords:  Leishmania; Leishmania amazonensis; aminoquinoline; mitochondrial membrane potential; reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 25682728     DOI: 10.1111/cbdd.12540

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  5 in total

1.  Novel Aminoquinoline Derivatives Significantly Reduce Parasite Load in Leishmania infantum Infected Mice.

Authors:  Jelena Konstantinović; Milica Videnović; Stefania Orsini; Katarina Bogojević; Sarah D'Alessandro; Diletta Scaccabarozzi; Nataša Terzić Jovanović; Luigi Gradoni; Nicoletta Basilico; Bogdan A Šolaja
Journal:  ACS Med Chem Lett       Date:  2018-05-04       Impact factor: 4.345

2.  Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.

Authors:  Débora Vasconcelos Costa Mendonça; Daniela Pagliara Lage; Stephane Lima Calixto; Flaviano Melo Ottoni; Grasiele de Sousa Vieira Tavares; Fernanda Ludolf; Miguel Angel Chávez-Fumagalli; Mônica Santos Schneider; Mariana Costa Duarte; Carlos Alberto Pereira Tavares; Ricardo José Alves; Elaine Soares Coimbra; Eduardo Antonio Ferraz Coelho
Journal:  Parasitol Res       Date:  2017-12-16       Impact factor: 2.289

Review 3.  Emerging therapeutic targets for treatment of leishmaniasis.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Opin Ther Targets       Date:  2018-05-09       Impact factor: 6.902

4.  Antileishmanial assessment of isoxazole derivatives against L. donovani.

Authors:  Sushobhan Mukhopadhyay; Dinesh S Barak; R Karthik; Sarvesh K Verma; Rabi S Bhatta; Neena Goyal; Sanjay Batra
Journal:  RSC Med Chem       Date:  2020-07-20

5.  Antileishmanial compounds from Connarus suberosus: Metabolomics, isolation and mechanism of action.

Authors:  Lais S Morais; Renata G Dusi; Daniel P Demarque; Raquel L Silva; Lorena C Albernaz; Sônia N Báo; Christian Merten; Luciana M R Antinarelli; Elaine S Coimbra; Laila S Espindola
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.